A recent study has found that alcoholics’ gait and balance can continue to recover with long-term abstinence from alcohol, but deficits, especially eyes-closed standing balance, can persist. The findings were published online on September 15 in Alcoholism: Clinical & Experimental Research. The researchers examined 70 short-term (6-15 weeks) and 82 long-term (minimum 18 months to [...]
Nov 6 2011 | Posted in
International |
Read More »
Robot-assisted therapy (RAT) has measurable benefits for patients with a weaker arm following a stroke, reported a Taiwan study in the August issue of Clinical Rehabilitation. The study, jointly conducted by the National Taiwan University, Chang Gung University and Taipei Hospital, enrolled 20 patients with mild-to-moderate upper limb impairment six months after a stroke. They [...]
Sep 28 2011 | Posted in
Asia-Other |
Read More »
A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into functioning brain cells, a breakthrough discovery that offers new hope for patients with neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. Published online in the scientific journal Cell Stem Cell, Dr Sheng Ding describes the methods for transforming adult [...]
Sep 8 2011 | Posted in
International |
Read More »
The natural form of vitamin E alpha-tocotrienol (TCT) was recently discovered to block an enzyme that releases fatty acids after a stroke. The researchers also found that TCT stops the action of a gene that leads to brain cell death and might be more potent than drugs targeting single mechanisms for preventing brain tissue damage [...]
Aug 18 2011 | Posted in
Biomedical |
Read More »
Eli Lilly has collaborated with Medtronic to research and develop an implantable drug delivery system to deliver a potential new medicine to the brain to treat Parkinson’s disease. The new therapeutic approach for Parkinson’s disease will combine the strengths of Lilly’s biologic, a modified form of glial cell-derived neurotrophic factor (GDNF), with Medtronic’s implantable drug [...]
Jun 8 2011 | Posted in
Features,
Industry |
Read More »
The US Food and Drug Administration has approved Horizant (gabapentin enacarbil) Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). RLS is a disorder that causes a strong urge to move the legs. This urge often occurs with unpleasant feelings in the legs. People who have RLS describe feeling pulling, itching, tingling, [...]
